REFERENCES
- Galassi G, Gentilini M, Ferrari S, et al. Motor neuron disease and HIV-1 infection in a 30-year-old HIV-positive heroin abuser: a causal relationship? Clin Neuropathol 1998; 17: 131–135.
- Nishio M, Koizumi K, Moriwaka F, Koike T, Sawada K. Reversal of HIV-associated motor neuron syndrome after high-ly active antiretroviral therapy. J Neurol 2001; 248: 233–234.
- Moulignier A, Moulonguet A, Pialoux G, Rozenbaum W. Reversible ALS-like disorder in HIV infection. Neurology 2001; 57: 995–1001.
- Westarp ME, Ferrante P, Perron H, Bartmann P, Kornhuber HH. Sporadic ALS/MND: a global neurodegeneration with retroviral involvement? J Neurol Sci 1995; 129(Suppl): 145–147.
- Jubelt B. Motor neuron diseases and viruses: poliovirus, retroviruses, and lymphomas. Curr Opin Neurol Neurosurg 1992; 5: 655–658.
- MacGowan DJ, Scelsa SN, Waldrom M. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 2001; 57: 1094–1097.
- Jubelt B, Berger JR. Does viral disease underlie ALS? Neurology 2001; 57: 945–946.
- Mulder DW, Rosenbaum RA, Layton DD. Late progres-sion of poliomyelitis or forme fruste amyotrophic lateral scle-rosis? Mayo Clin Proc 1972; 47: 756–761.
- Woodall CJ, Riding MH, Graham DI, Clements GB. Sequences specific for enterovirus detected in spinal cord from patients with MND. BMJ 1994; 308: 15–17.
- Jubelt B. Viruses and motor neuron disease. Adv Neurol 1991; 56: 463–472.
- Westarp ME, Schulz J, Von der Helm K, Bartmann P, Kornhuber HH. Nucleoside analogues in patients with spo-radic amyotrophic lateral sclerosis (sALS/cMND). Neurol Psychiatr Brain Res 1995; 3: 237–244.
- Ferrante P, Westarp ME, Mancuso R, et al. HTLV tax-rex DNA and antibodies in idiopathic amyotrophic lateral scle-rosis. J Neurol Sci 1995; 129: 140–144.
- Zoccolella S, Carbonara S, Minerva D, et al. A case of concomitant amyotrophic lateral sclerosis and HIV infection. Eur J Neurol 2002; 9: 180–182.
- Sastre-Garriga J, Tintorê M, Raguer N, Ruiz I, Montalban X, Codina A. Lower motor neuron disease in a HIV-2 infected woman. J Neurol 2000; 247 : 718–719.
- Yasojima K, Tourtellotte WW, McGeer EG, McGeer PL. Marked increased in cyclooxygenase-2 in ALS spinal cord: implications for therapy. Neurology 2001; 57: 952–957.
- Dyer JR, Edis RH, French MAH. Enterovirus associated neurological disease in an HIV-1 infected man. J Neurovirol 1998; 4: 569–571.
- Simpson DM, Morgello S, Citak K, Corbo M, Latov N. Motor neuron disease associated with HIV-1 and anti-asialo GM1 antibody. Muscle Nerve 1994; 17: 1091.
- Sloand EM, Kumar PN, Kim S, Chaudhuri A, Weichold FF, Young NS. Human immunodeficiency virus type I pro-tease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo. Blood 1994; 94: 1021-1027.
- Brouwers P, Civitello L, DeCarli C, Wolters P, Sei S. Cerebrospinal fluid viral load is related to cortical atrophy and not to intracerebral calcifications in children with symptomatic HIV disease. J Neurovirol 2000; 6: 390–397.